What this study is
The purpose of this study is collect observational data regarding patterns of care and outcomes of focal therapies for prostate cancer, including but not limited to: high-intensity focused ultrasound (HIFU), cryotherapy, focal laser ablation, irreversible electroporation, photodynamic therapy, and brachytherapy.
What's being tested
- cryotherapy
Intervention · DEVICE
Subjects will receive focal cryotherapy for treatment of prostate cancer
Study details
- Sponsor
- Weill Medical College of Cornell University
- Conditions
- Prostate Cancer
- Enrolling
- 200 people
- Starts
- 2018-01-02
- Est. completion
- 2039-09-02
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex MALEHealthy volunteers Not acceptedYou may qualify if
- >18 years of age
- Undergoing focal therapy for primary or salvage treatment of prostate cancer, or
- Have received prior focal therapy
You can't join if
- Clinically-evident metastatic disease
- Unable to fill out an English-language questionnaire
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openWeill Cornell Medicine
New York, New York, United States
- Holly Kuczynski · Contact646-962-7523hok4001@med.cornell.edu
- Tim McClure, M.D. · Principal investigator
Recruiting
Study team
Sponsor
Weill Medical College of Cornell University
Study ID 1702017952 prev. 1702018011
Principal investigator
Tim McClure, M.D.
Weill Medical College of Cornell University
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.